Home » Topics » Regulatory

Regulatory
RSS

FDA approves Arcalyst for cryopyrin-associated periodic syndromes (CAPS)

Feb. 29, 2008

FDA approves Abbott's Humira for polyarticular juvenile idiopathic arthritis

Feb. 25, 2008

FDA approves Abbott's Simcor, a combination therapy for cholesterol management

Feb. 18, 2008

FDA approves Emend for Injection as part of treatment for CINV

Jan. 30, 2008

Europe authorizes expanded use of The Medicines Company's Angiox in ACS

Jan. 29, 2008

Asahi Kasei obtains approval for recombinant thrombomodulin alpha

Jan. 29, 2008

Antibacterial Gracevit receives manufacturing and marketing approval in Japan

Jan. 28, 2008

Cangene's recombinant human growth hormone approved by the FDA

Jan. 28, 2008

FDA approves Welchol for glucose reduction in adults with type 2 diabetes

Jan. 21, 2008

FDA grants Intelence accelerated approval for HIV combination therapy

Jan. 21, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.